Abstract:To identify host factors that influence SARS-coronavirus (SARS-CoV) replication, we performed an siRNA library screen targeting the human kinome. Protein kinases are key regulators of many cellular functions and the systematic knockdown of their expression should provide a broad perspective on factors and pathways promoting or antagonizing coronavirus replication. In addition to 40 proviral proteins that promote SARS-CoV replication, our study identified 90 factors with an antiviral effect. Pathway analysis grouped subsets of these factors in specific cellular pathways, like the innate immune response and the metabolism of complex lipids, which thus appear to play an important role in SARS-CoV-infected cells. Two factors were selected for more extensive validation and follow-up experiments. In cells depleted for the beta 2 subunit of the coatomer protein complex (COPB2), the strongest proviral hit, we observed reduced SARS-CoV protein expression and a 2-log reduction in virus yield. The effect of knockdown of the COPB2-related factors COPB1 and Golgi-specific brefeldin A-resistance guanine nucleotide exchange factor 1 (GBF1) also suggested that COPI-coated vesicles and/or the early secretory pathway are important for SARS-CoV replication. Depletion of the antiviral double-stranded RNA-activated protein kinase (PKR) enhanced virus replication, and validation experiments using PKR-directed siRNAs confirmed increased SARS-CoV protein expression and virus production upon PKR depletion. The inventory of proand antiviral host factors and pathways described in this study expands our understanding of the replication of SARS-CoV, and may contribute to the identification of novel targets for antiviral therapy. Host factors in SARS-CoV replication 89 CH A PT ER 5 INTRODUCTION Positive-stranded RNA (+RNA) viruses interact with the infected host cell at many levels during their replicative cycle, and thus far numerous host cell proteins with a role in virus replication have been identified [60-65]. These include on the one hand host factors that are used by the virus during the various stages of its life cycle, and on the other hand factors that are part of the host defense against virus infection. Such proteins may constitute interesting targets in the development of novel antiviral strategies, as drug resistance is less likely to develop when cellular rather than viral functions are targeted. Antiviral drug resistance is a serious problem, in particular when combating RNA viruses, due to their high mutation rate and potential for rapid adaptation. Systems biology approaches have been instrumental in advancing our knowledge of individual proteins and cellular pathways that influence +RNA virus infection. For example, systematic functional genomics screens using small interfering RNA (siRNA) libraries have identified numerous host genes with a role in the replication of important human pathogens like West Nile virus [334], Dengue virus [335], human immunodeficiency virus 1 [336], hepatitis C virus [337-342], and influenza virus [338, 343, 344]. For coronaviruses a number of relevant host proteins were previously described ([321], and reviewed in [65, 320]), but the use of larger-scale siRNA screens to systematically identify such factors was not documented thus far. Coronaviruses, and other members of the order Nidovirales [286], have the largest RNA genomes known to date (27-31 kb [37]) and the complexity of their molecular biology clearly distinguishes them from other +RNA virus groups. Although infection with most human coronaviruses is associated with relatively mild respiratory disease [19, 345], the 2003 outbreak of severe acute respiratory syndrome (SARS) highlighted the potential of coronaviruses to cause lethal disease in humans. The zoonotic transfer of SARS-coronavirus (SARS-CoV), which likely originated from bats, initiated an outbreak that affected about 8,000 humans, with a mortality of about 10% [317]. Strikingly, a similar outbreak of coronavirus-induced severe respiratory disease has been developing in a number of Arab countries since April 2012, with 9 of the 15 confirmed cases thus far (March 2013) having a fatal outcome (http://www.who.int/csr/don/archive/disease/ coronavirus_infections/en/). The causative agent, human coronavirus EMC/2012, was recently identified as a previously unknown member of betacoronavirus subgroup 2c [15, 16]. Although the source of this emerging human pathogen remains to be identified, it is striking that – as in the case of SARS-CoV its closest known relatives are coronaviruses circulating in bats [16]. These recent developments highlight once again the relevance of the systematic dissection of coronavirus-host interactions and the development of antiviral approaches to combat coronavirus infection.

Genome-wide CRISPR Screens Reveal Host Factors Critical for SARS-CoV-2 Infection

Bidirectional genome-wide CRISPR screens reveal host factors regulating SARS-CoV-2, MERS-CoV and seasonal coronaviruses

Genome-wide CRISPR Activation Screen Identifies Candidate Receptors for SARS-CoV-2 Entry

Global siRNA Screen Reveals Critical Human Host Factors of SARS-CoV-2 Multicycle Replication

Identification of Required Host Factors for SARS-CoV-2 Infection in Human Cells

Bidirectional genome-wide CRISPR screens reveal host factors regulating SARS-CoV-2, MERS-CoV and seasonal HCoVs

Interaction network of SARS-CoV-2 with host receptome through spike protein

A genome-wide CRISPR screen identifies host factors that regulate SARS-CoV-2 entry

Genome-wide bidirectional CRISPR screens identify mucins as host factors modulating SARS-CoV-2 infection

Integrated multi-omics analyses identify anti-viral host factors and pathways controlling SARS-CoV-2 infection

Virus-Host Interactome and Proteomic Survey Reveal Potential Virulence Factors Influencing SARS-CoV-2 Pathogenesis

Author Correction: Receptome profiling identifies KREMEN1 and ASGR1 as alternative functional receptors of SARS-CoV-2

SARS-CoV-2 Receptor ACE2 is an Interferon-Stimulated Gene in Human Airway Epithelial Cells and Is Enriched in Specific Cell Subsets Across Tissues

Identification of Cellular Factors Required for SARS-CoV-2 Replication

Conserved Genomic Terminals of SARS-CoV-2 as Coevolving Functional Elements and Potential Therapeutic Targets

A kinome-wide siRNA screen identifies proviral and antiviral host factors in SARS-coronavirus replication, including PKR and early secretory pathway proteins

SARS-CoV-2 Receptor ACE2 Is an Interferon-Stimulated Gene in Human Airway Epithelial Cells and Is Detected in Specific Cell Subsets across Tissues

Determinants of SARS-CoV-2 Receptor Gene Expression in Upper and Lower Airways

A CRISPR Activation Screen Identifies Genes That Enhance SARS-CoV-2 Infection

A Kinome-Wide Small Interfering RNA Screen Identifies Proviral and Antiviral Host Factors in Severe Acute Respiratory Syndrome Coronavirus Replication, Including Double-Stranded RNA-Activated Protein Kinase and Early Secretory Pathway Proteins

A genome-wide arrayed CRISPR screen identifies PLSCR1 as an intrinsic barrier to SARS-CoV-2 entry that recent virus variants have evolved to resist